Chemistry:Formestane

From HandWiki
Revision as of 21:40, 5 February 2024 by Jslovo (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Formestane
Formestane.svg
Clinical data
Trade namesLentaron, others
Other names4-Hydroxyandrost-4-ene-3,17-dione
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Intramuscular injection
Drug classAromatase inhibitor; Antiestrogen
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
Chemical and physical data
FormulaC19H26O3
Molar mass302.414 g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Formestane, formerly sold under the brand name Lentaron among others, is a steroidal, selective aromatase inhibitor which is used in the treatment of estrogen receptor-positive breast cancer in postmenopausal women.[1] The drug is not active orally, and was available only as an intramuscular depot injection. Formestane was not approved by the United States FDA and the injectable form that was used in Europe in the past has been withdrawn from the market.[2] Formestane is an analogue of androstenedione.

Formestane is often used to suppress the production of estrogens from anabolic steroids or prohormones. It also acts as a prohormone to 4-hydroxytestosterone, an active steroid which displays weak androgenic activity in addition to acting as a weak aromatase inhibitor.


References

  1. "Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer". Ann. Oncol. 5 (Suppl 7): S19–24. 1994. PMID 7873457. 
  2. "Formestane". https://pubchem.ncbi.nlm.nih.gov/compound/formestane#section=Top.